ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 3053 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 3053; 2) Community: the network communities that were significantly associated with the response to NSC 3053; 3) Molecule: the relationships between components within communities and NSC 3053; 4) MDR: the compounds that were significantly associated with the NSC 3053.

NSC Compound Enrichment Correlation
NSC 201459 1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- 0.0131142867047949 0.047248192
NSC 217697 Quinoline, 6,6'-methylenebis[1,2-dihydro-2,2,4-trimethyl]- 0.0131142867047949 0.30886623
NSC 237671 Actinomycin X4357g-methoxime 0.0131142867047949 0.84789172
NSC 285706 SINULARIN 0.0131142867047949 0.25039936
NSC 295426 Propanoic acid, 2-methyl-, 2,3,3a,4,5,8,9,11a-octahydro-6,10-bis(hydroxymethyl)-3-methylene-2-oxocyclodeca[b]furan-4-yl ester, [3aR-(3aR*,4S*,6Z,10Z,11aR*)]- (9CI) 0.0131142867047949 0.22254688
NSC 30637 Null 0.0135712240673827 0.23848057
NSC 38535 2,6-Bis(4-morpholinylmethyl)cyclohexanone,dihydrochloride 0.0135712240673827 0.21306191
NSC 622626 Null 0.0135712240673827 0.32389232
NSC 627745 Null 0.0135712240673827 0.40277079
NSC 634784 4-Piperidinone, 1-[3-(dimethylamino)-1-oxopropyl]-3,5- bis(phenylmethylene)-, monohydrochloride 0.0135712240673827 0.49518906
Total:171  Current:79    [First] [Prev] [Next] [Last]